Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit
Read moreStudies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit
Read moreAlbert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy
Read moreDuring social interactions, the activity of the brain’s neurons becomes synchronized between the individuals involved. New research published in Advanced
Read moreLed by Helmholtz Munich, scientists have developed an accessible software solution specifically designed for the analysis of complex medical health
Read moreMore than a million people each year die from infections by pathogens that are resistant to antimicrobials, and the problem
Read moreUsing a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway
Read moreSuspicions that U.S. consumers’ personal information could be accessed from India led regulators to abruptly bar two large private sector
Read moreSmall interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases. However,
Read moreResearchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health
Read moreCognitive behavioral therapy, one of the most common treatments for depression, can teach skills for coping with everyday troubles, reinforce
Read more